Pharmacodynamics 2 (ppt 8) Flashcards

1
Q

Synergism

A
  • combined effect of 2 drugs is greater than the sum of their effects when given separately
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Additivity

A

A drug adds to the potency of the first drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Potentiation

A

One drug doesn’t cause a response on its own, but enhances the response of another drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prodrugs must be metabolized by…

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Magnitude of pharmacological response is proportionally related to

A

Drug conc. @ receptor site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

5 types of receptors or signaling mech. for drug actions

A
  • steroid
  • tyrosine kinase
  • JAK-STAT
  • ion channel
  • GPCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ligand gated ion-channel

A
  • 5 subunits: alpha, beta, gamma, delta
  • ACh binding to extracellular a subunit site=open channel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

G-protein coupled receptor

A
  • regulate effector proteins via mediation of transducers (g proteins)
  • ligands: hormones, pheromones, neurotransmitters, autacoids, xenobiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

G proteins

A
  • heterotrimeric molecules
  • 3 subunits attached to inner surface: alpha, beta, gamma
  • beta gamma comples
  • 4 families: G-alphas, G-alphai/G-alpha0, G-alpha q, G-alpha 12/13
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Enzyme-linked effector systems

A

Second messengers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Enzyme-linked effector system types

A
  • adenylate cyclase: cAMP system
  • Phospholipase C: IP3-DAG system
  • Phospholipase A2: A A system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gs family

A
  • alpha s subunit
  • positive action on adenylate cyclase & calcium channels
  • increase heart rate, stim. neuronal activity
  • ex: adrenergic beta-R
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gi/G0 family

A
  • alpha subunit: i & 0
  • negative effect on adenylate cyclase and Ca2+ channels
  • positive effect on K+ channel
  • smooth m. relaxant, depresses neuronal activity
  • ex: muscarinic M2-R, Opioid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gq/11 family

A
  • alpha subunits: q, 11, 14, 15, 16
  • positive effect on Phospholipase C
  • smooth m. contraction, Ca2+ flux
  • ex: adrenergic alpha 1R, Histamine H1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

G12/13 family

A
  • alpha subunits: 12 and 13
  • positive effects on Rho family of GTPases, and Na+/H+ exchange
  • cytoskeletal funct., smooth m. contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tyrosine kinase receptor (TKR) states

A
  • C1 State: inactive
  • C2 state: active
17
Q

C-1 state

A
  • transmembrane receptors have large extracellular binding sites, intracellular tails, and enxyme
18
Q

C-2 state

A
  • ligan binds to both receptors, dimer formed, tyrosine kinase portion activated, ATP phosphorylates tyrosines on tail of other polypeptide, downstream signaling
19
Q

Nuclear receptors

A
  • may be located in cytosol and migrate to nucleus post-binding
  • long-lasting effect
  • Ex: glucocorticoid receptos
20
Q

Up-regulation of receptors

A
  • body increases # of receptors
  • seen when receptors continuously deprived of ligands or continued antagonist use
  • state of supersensitization
  • ex: rebound hypertension in K9s following withdrawal of beta-adrenoceptor blockers (atenolol)
21
Q

Down-regulation

A
  • cell decreases # receptors or protein population
  • diminishes drug effects (tissues continuously exposed to agonist-> over-activation)
  • drug-receptor complex undergoes endocytosis then metabolized
  • leads to desensitization or refractoriness
  • ex: continuous exposure to insulin